AU1626199A - A vi-repa conjugate vaccine for immunization against salmonella typhi - Google Patents
A vi-repa conjugate vaccine for immunization against salmonella typhiInfo
- Publication number
- AU1626199A AU1626199A AU16261/99A AU1626199A AU1626199A AU 1626199 A AU1626199 A AU 1626199A AU 16261/99 A AU16261/99 A AU 16261/99A AU 1626199 A AU1626199 A AU 1626199A AU 1626199 A AU1626199 A AU 1626199A
- Authority
- AU
- Australia
- Prior art keywords
- salmonella typhi
- conjugate vaccine
- immunization against
- against salmonella
- repa conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/025746 WO2000033882A1 (en) | 1998-12-04 | 1998-12-04 | A vi-repa conjugate vaccine for immunization against salmonella typhi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1626199A true AU1626199A (en) | 2000-06-26 |
Family
ID=22268424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16261/99A Abandoned AU1626199A (en) | 1998-12-04 | 1998-12-04 | A vi-repa conjugate vaccine for immunization against salmonella typhi |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1626199A (en) |
| WO (1) | WO2000033882A1 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7082569B2 (en) | 2001-01-17 | 2006-07-25 | Outlooksoft Corporation | Systems and methods providing dynamic spreadsheet functionality |
| CA2611960C (en) | 2005-06-27 | 2015-05-05 | Glaxosmithkline Biologicals S.A. | Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| DK2200642T3 (en) | 2007-10-19 | 2012-07-16 | Novartis Ag | Meningococcal vaccine preparations |
| CA2716212A1 (en) | 2008-02-21 | 2009-08-27 | Novartis Ag | Meningococcal fhbp polypeptides |
| DK2349520T3 (en) | 2008-10-27 | 2016-08-15 | Glaxosmithkline Biologicals Sa | Purification Procedure for Group A Streptococcus Carbohydrate |
| GB0822633D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| AU2010227219B2 (en) | 2009-03-24 | 2014-02-27 | Glaxosmithkline Biologicals S.A. | Adjuvanting meningococcal factor H binding protein |
| JP5668049B2 (en) | 2009-03-24 | 2015-02-12 | ノバルティス アーゲー | Combination of meningococcal factor H binding protein and pneumococcal saccharide conjugate |
| EP3263128A3 (en) | 2009-04-14 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Compositions for immunising against staphylococcus aureus |
| CA2772104A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Hybrid polypeptides including meningococcal fhbp sequences |
| BR112012008338A2 (en) | 2009-09-10 | 2019-09-24 | Novartis Ag | combination of vaccines against respiratory tract diseases. |
| CN102724988B (en) | 2009-09-30 | 2014-09-10 | 诺华股份有限公司 | Expression of meningococcal fHBP polypeptides |
| CA2779816A1 (en) | 2009-10-27 | 2011-05-05 | Novartis Ag | Modified meningococcal fhbp polypeptides |
| GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| GB201003333D0 (en) | 2010-02-26 | 2010-04-14 | Novartis Ag | Immunogenic proteins and compositions |
| GB201005625D0 (en) | 2010-04-01 | 2010-05-19 | Novartis Ag | Immunogenic proteins and compositions |
| AU2011268507B2 (en) | 2010-06-25 | 2014-08-14 | Novartis Ag | Combinations of meningococcal factor H binding proteins |
| GB201101665D0 (en) | 2011-01-31 | 2011-03-16 | Novartis Ag | Immunogenic compositions |
| EP2667852B1 (en) | 2011-01-27 | 2016-11-09 | GlaxoSmithKline Biologicals SA | Adjuvant nanoemulsions with crystallisation inhibitors |
| RU2013144207A (en) | 2011-03-02 | 2015-04-10 | Новартис Аг | COMBINED VACCINES WITH REDUCED DOSES OF ANTIGEN AND / OR ADJUVANT |
| WO2012129483A1 (en) | 2011-03-24 | 2012-09-27 | Novartis Ag | Adjuvant nanoemulsions with phospholipids |
| GB201114923D0 (en) | 2011-08-30 | 2011-10-12 | Novartis Ag | Immunogenic proteins and compositions |
| CN103917245B (en) | 2011-09-14 | 2017-06-06 | 葛兰素史密丝克莱恩生物有限公司 | Method for preparing glycoprotein glycoconjugate |
| CA2854934A1 (en) | 2011-11-07 | 2013-05-16 | Novartis Ag | Carrier molecule comprising a spr0096 and a spr2021 antigen |
| GB201121301D0 (en) | 2011-12-12 | 2012-01-25 | Novartis Ag | Method |
| CA2862247A1 (en) | 2011-12-29 | 2013-07-04 | Novartis Ag | Adjuvanted combinations of meningococcal factor h binding proteins |
| EP2822586A1 (en) | 2012-03-07 | 2015-01-14 | Novartis AG | Adjuvanted formulations of streptococcus pneumoniae antigens |
| US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
| JP6266000B2 (en) | 2012-10-03 | 2018-01-24 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Immunogenic composition |
| RS56886B1 (en) | 2012-11-30 | 2018-04-30 | Glaxosmithkline Biologicals Sa | Pseudomonas antigens and antigen combinations |
| CN105188747A (en) | 2013-02-01 | 2015-12-23 | 葛兰素史密斯克莱生物公司 | Intradermal delivery of immunological compositions comprising TOLL-like receptor agonists |
| CN105744951B (en) * | 2013-08-24 | 2021-03-16 | 巴拉特生物技术国际有限公司 | Bacterial vaccines and methods of making the same |
| MX2016011176A (en) | 2014-02-28 | 2017-02-23 | Glaxosmithkline Biologicals Sa | Modified meningococcal fhbp polypeptides. |
| BE1024634B1 (en) | 2016-04-05 | 2018-05-14 | Gsk Vaccines S.R.L. | IMMUNOGENIC COMPOSITIONS |
| WO2017187448A1 (en) * | 2016-04-25 | 2017-11-02 | National Institute Of Immunology | A novel conjugate for vaccination against typhoid comprising chemical conjugate of vi polysaccharide and flagellin, a process for producing the same and a composition comprising the conjugate |
| CN106990188B (en) * | 2017-06-09 | 2019-11-15 | 齐齐哈尔医学院 | A kind of high-efficiency liquid chromatography method for detecting of Pseudomonas aeruginosa Exotoxin A |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| GB202208093D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| GB202208089D0 (en) | 2022-06-01 | 2022-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
-
1998
- 1998-12-04 AU AU16261/99A patent/AU1626199A/en not_active Abandoned
- 1998-12-04 WO PCT/US1998/025746 patent/WO2000033882A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000033882A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1626199A (en) | A vi-repa conjugate vaccine for immunization against salmonella typhi | |
| EP1014787A4 (en) | Adjuvant for transcutaneous immunization | |
| AU4781297A (en) | Vaccines | |
| EP0682945A3 (en) | Oral sustained release preparation. | |
| AU2120197A (en) | Salmonella typhimurium vaccine | |
| GB9812613D0 (en) | Vaccine | |
| HUP9601466A2 (en) | Adjuvants for viral vaccines | |
| AU2001258279A1 (en) | Adjuvant for vaccines | |
| AU3154395A (en) | Contraceptive vaccine | |
| AU2462899A (en) | Live vaccine against brucellosis | |
| AU2769595A (en) | Contraceptive vaccine | |
| AU1420897A (en) | Conjugate vaccine for (salmonella paratyphi) a | |
| ZA9610102B (en) | Salmonella vaccines. | |
| AU4450696A (en) | Enhanced immunogenic vaccine | |
| GB9626864D0 (en) | Vaccine | |
| GB0027072D0 (en) | Vaccine | |
| GB9611673D0 (en) | Meningococcal vaccine | |
| HUP0104552A3 (en) | Oral vaccine against diarrhea | |
| GB9704977D0 (en) | FIV vaccine | |
| AU5739999A (en) | Salmonella typhi vaccine compositions | |
| IL109519A0 (en) | Vaccines for oral immunization against infecting agents | |
| ZA98738B (en) | Mutant enterotoxin effective as a non-toxic adjuvant for hiv. | |
| GB9625968D0 (en) | Vaccine | |
| PL346645A1 (en) | IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE | |
| AU3360797A (en) | Vaccine against gastro-intestinal nematodes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |